Drug approval in Europe

被引:0
|
作者
Walsh, Gary
机构
来源
Nature Biotechnology | 1999年 / 17卷 / 03期
关键词
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [1] Drug approval in Europe
    Walsh G.
    Nature Biotechnology, 1999, 17 (3) : 237 - 240
  • [2] A New Approach to Psychiatric Drug Approval in Europe
    Barbui, Corrado
    Bighelli, Irene
    PLOS MEDICINE, 2013, 10 (10)
  • [3] A New and Fast Drug Approval System in Europe
    Fernand Sauer
    Drug information journal : DIJ / Drug Information Association, 1997, 31 (1): : 1 - 6
  • [4] TIME ANALYSIS OF THE DRUG APPROVAL PROCESS IN EUROPE
    Martinez-Rodriguez, I
    Uria, E.
    Pomares, E.
    Cuesta, M.
    VALUE IN HEALTH, 2018, 21 : S156 - S156
  • [5] Cancer drug approval in the United States, Europe, and Japan
    Milsted, R. A. V.
    ADVANCES IN CANCER RESEARCH, VOL 96, 2007, 96 : 371 - 391
  • [6] New drug approval success rate in Europe in 2009
    Hans-Georg Eichler
    Bo Aronsson
    Eric Abadie
    Tomas Salmonson
    Nature Reviews Drug Discovery, 2010, 9 : 355 - 356
  • [7] New drug approval success rate in Europe in 2009
    Eichler, Hans-Georg
    Aronsson, Bo
    Abadie, Eric
    Salmonson, Tomas
    NATURE REVIEWS DRUG DISCOVERY, 2010, 9 (05) : 355 - 356
  • [8] EMERGING ROLE OF PATIENT REPORTED OUTCOMES IN DRUG APPROVAL IN EUROPE
    Pal, S.
    Magimaidas, R., V
    Sreedharan, S.
    Ghosh, S.
    Chatterjee, M.
    VALUE IN HEALTH, 2022, 25 (12) : S238 - S238
  • [9] Conditional Approval and Approval Under Exceptional Circumstances as Regulatory Instruments for Stimulating Responsible Drug Innovation in Europe
    Boon, W. P. C.
    Moors, E. H. M.
    Meijer, A.
    Schellekens, H.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2010, 88 (06) : 848 - 853
  • [10] Drug approval
    Kagan, B
    CHEMICAL & ENGINEERING NEWS, 1996, 74 (10) : 40 - 41